Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - Integrity Applications, Inc. | exhibit_99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 28, 2013
Integrity Applications, Inc.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 000-54785 | 98-0668934 |
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
|
102 Ha’Avoda Street, P.O. Box 432, Ashkelon, Israel
|
L3 78100 |
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: 972 (8) 675-7878
N/A
| (Former Name or Former Address, if Changed Since Last Report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 7.01. Regulation FD Disclosure.
On February 28, 2013 and March 1, 2013, Integrity Applications, Inc., a Delaware corporation (the “Company”), will present at the Advanced Technologies & Treatments for Diabetes conference in Paris, France (the “ATTD Conference”). A copy of a “poster” to be presented by the Company at the ATTD Conference is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference in this Item 7.01.
The information contained in this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing by the Company under the Exchange Act or the Securities Act of 1933, as amended.
ITEM 9.01. Financial Statements and Exhibits.
|
|
(d) Exhibits.
|
|
Exhibit Number
|
Description
|
|
|
99.1
|
Poster to be presented by the Company at the ATTD Conference
|
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 28, 2013
|
INTEGRITY APPLICATIONS, INC.
|
|||
|
|
By:
|
/s/ Avner Gal | |
| Name: Avner Gal | |||
| Title: Chief Executive Officer | |||
EXHIBIT INDEX
|
Exhibit Number
|
Description
|
|
|
99.1
|
Poster to be presented by the Company at the ATTD Conference
|